Comprehensive Analysis of the Expression of TGF-β Signaling Regulators and Prognosis in Human Esophageal Cancer

Figure 3

Genetic alteration differences of TGF-β signaling regulators in EC patients. (a) The genetic alteration of TGF-β signaling regulators in EC patients. (b) The mutation, amplification, and deep deletion were the most common types of alteration in different EC subtypes. (c) The hotspot mutations of SMAD2, SMAD7, ACVR2A, TGFBR2, and SMAD4.

(a)

(b)

(c)